<DOC>
	<DOCNO>NCT02351284</DOCNO>
	<brief_summary>To determine prevalence hypovitaminosis D HIV infect patient , consequence secondary hyperparathyroidism , bone mineral density ( BMD ) . Also , establish improvement vitamin D status , parathyroid hormone ( PTH ) BMD , case receive vitamin D supplementation , follow period least 1 year .</brief_summary>
	<brief_title>Impact Hypovitaminosis D Bone Disease HIV Infected Patients</brief_title>
	<detailed_description>This study deal impact vitamin D metabolism bone health HIV infect patient . To answer question importance hormone population , design cohort study prevalence vitamin D deficiency ( measure 25-hydroxy-vitamin D ) , classify severe deficiency ( &lt; 10 ng/ml ) , deficiency ( &lt; 20 ng/ml ) , insufficiency ( &lt; 30 ng/ml ) , relationship secondary hyperparathyroidism ( PTH &gt; 65 pg/ml ) , related BMD dual X-ray absorptiometry ( DXA ) . These result adjust baseline factor , age , gender , body mass index ( BMI ) , hepatitis C virus ( HCV ) coinfection , risk practice HIV infection , CD4+ count , antiretroviral therapy , HIV RNA level . In patient receive vitamin D supplementation accord clinical decision , evaluate change percentage hypovitaminosis D and/or secondary hyperparathyroidism , effect BMD . Bone biomarkers collect determine impact change secondary vitamin D improvement bone evolution .</detailed_description>
	<mesh_term>Avitaminosis</mesh_term>
	<mesh_term>Rickets</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<criteria>HIV old 18 year Chronic kidney disease stage 4 5 ( creatinine clearance &lt; 30 ml/min ) Pregnancy Uso corticosteroid therapy , require antiresorptive treatment Prolonged hospitalization internment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>HIV , vitamin D , osteoporosis</keyword>
</DOC>